LLMs/AA/AI opportunities?
Chairs: Paulo Bargo & Ning Leng
See also: 2024 Discussion
Question
What should we be doing to leverage advances in LLMs/AA/AI impact? (at the drug development through to developer efficiency levels)
WarningMissing notes
Notes are not available for this roundtable.